By the Numbers: NVO
NVO - Novo Nordisk A/S - Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.
Some CAPS Information
5 Star Rating
Total Debt-to-Equity Ratio = 0.03
Return on Equity (TTM) = 29.40
Price-to-Earnings (TTM) = 22.70
Price-to-Book (TTM) = 7.05
Do you think this is a great buy, or is this stock going to underperform for the next few years?